These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31462543)

  • 1. Tumor microenvironment and immunology of ovarian cancer: 12th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Mitra AK; Yang-Hartwich Y
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s12-s15. PubMed ID: 31462543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Maihle NJ; Levine DA; Dhillon K; Armstrong DK
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s1. PubMed ID: 31462540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Summaries: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Armstrong DK
    Int J Gynecol Cancer; 2017 Nov; 27(9S Suppl 5):S1. PubMed ID: 29278598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics and molecular mechanisms of high grade serous ovarian cancer: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Rankin EB
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s7-s11. PubMed ID: 31462542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment and Models of Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    McLean K; Mehta G
    Int J Gynecol Cancer; 2017 Nov; 27(9S Suppl 5):S2-S9. PubMed ID: 29049091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Johnson N; Liao JB
    Int J Gynecol Cancer; 2017 Nov; 27(9S Suppl 5):S14-S19. PubMed ID: 29040190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting report from the 2018 12th Biennial Ovarian Cancer Research Symposium detection and prevention of ovarian cancer.
    Xian W; George S
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s2-s6. PubMed ID: 31462541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.
    Chien J; Poole EM
    Int J Gynecol Cancer; 2017 Nov; 27(9S Suppl 5):S20-S22. PubMed ID: 29278600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophage-targeted therapeutics in ovarian cancer.
    An Y; Yang Q
    Int J Cancer; 2021 Jul; 149(1):21-30. PubMed ID: 33231290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutics: response and resistance in ovarian cancer.
    Zamarin D
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s16-s21. PubMed ID: 31462544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting Report From the 2016 11th Biennial Ovarian Cancer Research Symposium: Mechanisms of Initiation and Progression of Ovarian Cancers.
    Chien J; Mehta G
    Int J Gynecol Cancer; 2017 Nov; 27(9S Suppl 5):S10-S13. PubMed ID: 29278599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
    Ray M; Ruffalo MM; Bar-Joseph Z
    Genes Chromosomes Cancer; 2019 Jan; 58(1):34-42. PubMed ID: 30285311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?
    Chiriva-Internati M; Cobos E; Cannon MJ
    Int Rev Immunol; 2011; 30(2-3):67-70. PubMed ID: 21557634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the immune microenvironment in ovarian cancer patients.
    Yang L; Wang S; Zhang Q; Pan Y; Lv Y; Chen X; Zuo Y; Hao D
    Mol Omics; 2018 Oct; 14(5):341-351. PubMed ID: 30129640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cancer Research Institute 2013 Annual Symposium: Dynamics of host-tumor interaction.
    Tontonoz M; Gee CE
    Cancer Immunol Res; 2014 Feb; 2(2):105-11. PubMed ID: 24778274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian Cancer Immunotherapy: Turning up the Heat.
    Ghisoni E; Imbimbo M; Zimmermann S; Valabrega G
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivor advocacy: I speak for those who can't.
    Powell SS
    Int J Gynecol Cancer; 2019 Aug; 29(Suppl 2):s22-s23. PubMed ID: 31462545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ironing Out the Kinks: Arming Natural Killer Cells against Ovarian Cancer.
    Bell HN; Zou W
    Cancer Discov; 2024 Oct; 14(10):1771-1773. PubMed ID: 39363745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance.
    Kandalaft LE; Motz GT; Duraiswamy J; Coukos G
    Cancer Metastasis Rev; 2011 Mar; 30(1):141-51. PubMed ID: 21298574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.